ExpertiseUpdated on 13 April 2026
Rapid Diagnostics & Countermeasures
Director at Lithuanian population and rare disorders biobank
Lithuania
About
Fast validation using real-world data: Access to diverse, well-characterized biospecimens enables rapid testing and benchmarking of diagnostic tools across populations and exposure scenarios.
Translational testing environment: VU MF infrastructure supports end-to-end validation—from biomarker discovery to clinically relevant prototypes, including field-deployable solutions.
Countermeasure development support: Data and samples enable evaluation of vaccines, therapeutics, and response strategies against infectious, toxic, or CBRN-related threats.
Operational impact for defence: Faster deployment of reliable diagnostics; Improved response to biological and hybrid threats; Evidence-based development of medical countermeasures
This creates a dual-use platform for rapid, scalable solutions aligned with NATO preparedness and response priorities.
Organisation
Similar opportunities
Expertise
Biosurveillance & Early Threat Detection
GIEDRĖ KVEDARAVIČIENĖ
Director at Lithuanian population and rare disorders biobank
Lithuania
Expertise
GIEDRĖ KVEDARAVIČIENĖ
Director at Lithuanian population and rare disorders biobank
Lithuania
Expertise
Data-Driven Decision Support & AI
GIEDRĖ KVEDARAVIČIENĖ
Director at Lithuanian population and rare disorders biobank
Lithuania